Pastan I - Search Results

1

Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment.

Reiter Y, Pai LH, Brinkmann U, Wang QC, Pastan I. Reiter Y, et al. Among authors: pastan i. Cancer Res. 1994 May 15;54(10):2714-8. Cancer Res. 1994. PMID: 8168102

2

Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice.

Mickisch GH, Pai LH, Gottesman MM, Pastan I. Mickisch GH, et al. Among authors: pastan i. Cancer Res. 1992 Aug 15;52(16):4427-32. Cancer Res. 1992. PMID: 1353705

3

Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys.

Pai LH, Batra JK, FitzGerald DJ, Willingham MC, Pastan I. Pai LH, et al. Among authors: pastan i. Cancer Res. 1992 Jun 1;52(11):3189-93. Cancer Res. 1992. PMID: 1591729

4

Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium.

Chang K, Pai LH, Batra JK, Pastan I, Willingham MC. Chang K, et al. Among authors: pastan i. Cancer Res. 1992 Jan 1;52(1):181-6. Cancer Res. 1992. PMID: 1727378

5

B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice.

Brinkmann U, Pai LH, FitzGerald DJ, Willingham M, Pastan I. Brinkmann U, et al. Among authors: pastan i. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8616-20. doi: 10.1073/pnas.88.19.8616. Proc Natl Acad Sci U S A. 1991. PMID: 1924323 Free PMC article.

6

Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40).

Pai LH, Gallo MG, FitzGerald DJ, Pastan I. Pai LH, et al. Among authors: pastan i. Cancer Res. 1991 Jun 1;51(11):2808-12. Cancer Res. 1991. PMID: 2032221

7

Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice.

Pai LH, FitzGerald DJ, Tepper M, Schacter B, Spitalny G, Pastan I. Pai LH, et al. Among authors: pastan i. Cancer Res. 1990 Dec 15;50(24):7750-3. Cancer Res. 1990. PMID: 2253218

8

Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude mice.

Benhar I, Reiter Y, Pai LH, Pastan I. Benhar I, et al. Among authors: pastan i. Int J Cancer. 1995 Jul 28;62(3):351-5. doi: 10.1002/ijc.2910620320. Int J Cancer. 1995. PMID: 7628878

9

Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells.

Kunwar S, Pai LH, Pastan I. Kunwar S, et al. Among authors: pastan i. J Neurosurg. 1993 Oct;79(4):569-76. doi: 10.3171/jns.1993.79.4.0569. J Neurosurg. 1993. PMID: 7692018

10

Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structure.

Reiter Y, Kurucz I, Brinkmann U, Jung SH, Lee B, Segal DM, Pastan I. Reiter Y, et al. Among authors: pastan i. Immunity. 1995 Mar;2(3):281-7. doi: 10.1016/1074-7613(95)90052-7. Immunity. 1995. PMID: 7697545 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,282 results

Search Page

Filters